Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation

Jae Hee Seo; Yun Hye Jin; Hyung Min Jeong; Yeon Jin Kim; Hye Gwang Jeong; Chang Yeol Yeo; Kwang Youl Lee

doi:10.1016/j.bbrc.2009.04.082

Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation

Jae Hee Seo, Yun Hye Jin, Hyung Min Jeong, Yeon Jin Kim, Hye Gwang Jeong, Chang Yeol Yeo, Kwang Youl Lee

Department of Life Science

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Calmodulin-dependent kinase II (CaMKII) acts as a key regulator of osteoblast differentiation. CaMKII is a Ca²⁺-activated serine/threonine kinase and it regulates the activity of target proteins by phosphorylation. Dlx5 transcription factor plays crucial roles in osteoblast differentiation. The expression of Dlx5 is regulated by several osteogenic signaling pathways from early stages of osteoblastogenesis. In addition, Dlx5 can be phosphorylated and activated by p38, suggesting that the function of Dlx5 can be also modulated by post-translational modification. Although CaMKII and Dlx5 both play crucial roles during osteoblast differentiation, the interaction between CaMKII and Dlx5 has not been investigated. In the current study, we examined the effects CamKII on the function of Dlx5. We found that CaMKII phosphorylates Dlx5, and that CaMKII increases the protein stability and the osteoblastogenic transactivation activity of Dlx5. Conversely, a CaMKII inhibitor KN-93 decreased the osteogenic and transactivation activities of Dlx5. These results indicate that CaMKII regulates osteoblast differentiation, at least in part, by increasing the protein stability and the transcriptional activity of Dlx5.

Original language	English
Pages (from-to)	100-104
Number of pages	5
Journal	Biochemical and Biophysical Research Communications
Volume	384
Issue number	1
DOIs	https://doi.org/10.1016/j.bbrc.2009.04.082
State	Published - 19 Jun 2009

Bibliographical note

Funding Information:
This work was supported by Korean Research Foundation Grant funded by Korean Government (MOEHRD, Basic Research Fund, KRF-2006-311-E00120) to K.-Y. Lee. Y.-J. Kim is supported by the second stage of Brain Korea 21 Project.

Keywords

Calmodulin-dependent kinase II
Dlx5
Osteoblast differentiation
Protein stability

Access to Document

10.1016/j.bbrc.2009.04.082

Cite this

@article{93d76c13f6574df5bec5c144be93fd53,

title = "Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation",

abstract = "Calmodulin-dependent kinase II (CaMKII) acts as a key regulator of osteoblast differentiation. CaMKII is a Ca2+-activated serine/threonine kinase and it regulates the activity of target proteins by phosphorylation. Dlx5 transcription factor plays crucial roles in osteoblast differentiation. The expression of Dlx5 is regulated by several osteogenic signaling pathways from early stages of osteoblastogenesis. In addition, Dlx5 can be phosphorylated and activated by p38, suggesting that the function of Dlx5 can be also modulated by post-translational modification. Although CaMKII and Dlx5 both play crucial roles during osteoblast differentiation, the interaction between CaMKII and Dlx5 has not been investigated. In the current study, we examined the effects CamKII on the function of Dlx5. We found that CaMKII phosphorylates Dlx5, and that CaMKII increases the protein stability and the osteoblastogenic transactivation activity of Dlx5. Conversely, a CaMKII inhibitor KN-93 decreased the osteogenic and transactivation activities of Dlx5. These results indicate that CaMKII regulates osteoblast differentiation, at least in part, by increasing the protein stability and the transcriptional activity of Dlx5.",

keywords = "Calmodulin-dependent kinase II, Dlx5, Osteoblast differentiation, Protein stability",

author = "Seo, {Jae Hee} and Jin, {Yun Hye} and Jeong, {Hyung Min} and Kim, {Yeon Jin} and Jeong, {Hye Gwang} and Yeo, {Chang Yeol} and Lee, {Kwang Youl}",

note = "Funding Information: This work was supported by Korean Research Foundation Grant funded by Korean Government (MOEHRD, Basic Research Fund, KRF-2006-311-E00120) to K.-Y. Lee. Y.-J. Kim is supported by the second stage of Brain Korea 21 Project.",

year = "2009",

month = jun,

day = "19",

doi = "10.1016/j.bbrc.2009.04.082",

language = "English",

volume = "384",

pages = "100--104",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation

AU - Seo, Jae Hee

AU - Jin, Yun Hye

AU - Jeong, Hyung Min

AU - Kim, Yeon Jin

AU - Jeong, Hye Gwang

AU - Yeo, Chang Yeol

AU - Lee, Kwang Youl

N1 - Funding Information: This work was supported by Korean Research Foundation Grant funded by Korean Government (MOEHRD, Basic Research Fund, KRF-2006-311-E00120) to K.-Y. Lee. Y.-J. Kim is supported by the second stage of Brain Korea 21 Project.

PY - 2009/6/19

Y1 - 2009/6/19

N2 - Calmodulin-dependent kinase II (CaMKII) acts as a key regulator of osteoblast differentiation. CaMKII is a Ca2+-activated serine/threonine kinase and it regulates the activity of target proteins by phosphorylation. Dlx5 transcription factor plays crucial roles in osteoblast differentiation. The expression of Dlx5 is regulated by several osteogenic signaling pathways from early stages of osteoblastogenesis. In addition, Dlx5 can be phosphorylated and activated by p38, suggesting that the function of Dlx5 can be also modulated by post-translational modification. Although CaMKII and Dlx5 both play crucial roles during osteoblast differentiation, the interaction between CaMKII and Dlx5 has not been investigated. In the current study, we examined the effects CamKII on the function of Dlx5. We found that CaMKII phosphorylates Dlx5, and that CaMKII increases the protein stability and the osteoblastogenic transactivation activity of Dlx5. Conversely, a CaMKII inhibitor KN-93 decreased the osteogenic and transactivation activities of Dlx5. These results indicate that CaMKII regulates osteoblast differentiation, at least in part, by increasing the protein stability and the transcriptional activity of Dlx5.

AB - Calmodulin-dependent kinase II (CaMKII) acts as a key regulator of osteoblast differentiation. CaMKII is a Ca2+-activated serine/threonine kinase and it regulates the activity of target proteins by phosphorylation. Dlx5 transcription factor plays crucial roles in osteoblast differentiation. The expression of Dlx5 is regulated by several osteogenic signaling pathways from early stages of osteoblastogenesis. In addition, Dlx5 can be phosphorylated and activated by p38, suggesting that the function of Dlx5 can be also modulated by post-translational modification. Although CaMKII and Dlx5 both play crucial roles during osteoblast differentiation, the interaction between CaMKII and Dlx5 has not been investigated. In the current study, we examined the effects CamKII on the function of Dlx5. We found that CaMKII phosphorylates Dlx5, and that CaMKII increases the protein stability and the osteoblastogenic transactivation activity of Dlx5. Conversely, a CaMKII inhibitor KN-93 decreased the osteogenic and transactivation activities of Dlx5. These results indicate that CaMKII regulates osteoblast differentiation, at least in part, by increasing the protein stability and the transcriptional activity of Dlx5.

KW - Calmodulin-dependent kinase II

KW - Dlx5

KW - Osteoblast differentiation

KW - Protein stability

UR - http://www.scopus.com/inward/record.url?scp=65549149859&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.04.082

DO - 10.1016/j.bbrc.2009.04.082

M3 - Article

C2 - 19393622

AN - SCOPUS:65549149859

SN - 0006-291X

VL - 384

SP - 100

EP - 104

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

IS - 1

ER -

Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this